77T-33684-94172
1 vaccination
2 coded responses
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 928 / CA
- Registered
- 2022-06-26
- Relationship
- Child or adolescent in my care
- Guardian
- JAD-14577-09002
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-06-25
Dose 1 — Pfizer-BioNTech
-
2022-06-26
Registered in v-safe
-
2022-06-26
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-01
- 2022-07-02
- 2022-07-09
- 2022-09-24
-
2022-12-26
Survey response — 6 months, dose 1, dependentMedDRA: Viral infection — Feeling: Good · Be unable to work or attend schoolFree text: She has had several viruses.MedDRA releases: 2024-11 · check-in free text available
-
2023-06-25
Survey response — 12 months, dose 1, dependentMedDRA: Viral infection — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-25 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 1, dependent
Symptoms: She has had several viruses.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release